Herve Mommeja-Marin

Summary

Publications

  1. ncbi request reprint Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature
    Herve Mommeja-Marin
    Triangle Pharmaceuticals, Inc, Durham, NC 27717, USA
    Hepatology 37:1309-19. 2003
  2. ncbi request reprint A phase II dose-escalating trial of clevudine in patients with chronic hepatitis B
    Patrick Marcellin
    Service d Hepatologie, Hopital Beaujon, Clichy, France
    Hepatology 40:140-8. 2004
  3. pmc Comparison of real-time PCR assays for monitoring serum hepatitis B virus DNA levels during antiviral therapy
    Chee Kin Hui
    Department of Medicine, University of Hong Kong, Hong Kong, SAR, China
    J Clin Microbiol 44:2983-7. 2006
  4. ncbi request reprint Severe hepatotoxicity associated with nevirapine use in HIV-infected subjects
    Ian Sanne
    Clinical HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa
    J Infect Dis 191:825-9. 2005

Collaborators

Detail Information

Publications4

  1. ncbi request reprint Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature
    Herve Mommeja-Marin
    Triangle Pharmaceuticals, Inc, Durham, NC 27717, USA
    Hepatology 37:1309-19. 2003
    ..In conclusion, the goal of anti-HBV therapy should be profound and durable viral suppression, as defined by very sensitive assays. Additional prospective studies are needed to precisely determine the desirable level of viremia to attain...
  2. ncbi request reprint A phase II dose-escalating trial of clevudine in patients with chronic hepatitis B
    Patrick Marcellin
    Service d Hepatologie, Hopital Beaujon, Clichy, France
    Hepatology 40:140-8. 2004
    ..The pharmacokinetic profile of clevudine was proportional to the dose. In conclusion, these results demonstrate the tolerability and potent activity of clevudine in HBV-infected patients and support further clinical study...
  3. pmc Comparison of real-time PCR assays for monitoring serum hepatitis B virus DNA levels during antiviral therapy
    Chee Kin Hui
    Department of Medicine, University of Hong Kong, Hong Kong, SAR, China
    J Clin Microbiol 44:2983-7. 2006
    ..The results of the RealART and Digene Hybrid assays were related (r = 0.94; P < 0.001) and diverged by 2 orders of magnitude. The RealART assay can be used to effectively monitor serum hepatitis B virus DNA levels...
  4. ncbi request reprint Severe hepatotoxicity associated with nevirapine use in HIV-infected subjects
    Ian Sanne
    Clinical HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa
    J Infect Dis 191:825-9. 2005
    ..The use of nevirapine in female patients with a low BMI should be discouraged...